30 March 1990
COMMERCIAL ITEM DESCRIPTION
FUROSEMIDE INJECTION, USP
The General Services Administration has authorized the use of this Commercial Item Description as a replacement for Military Specification MIL-F-37141 which is cancelled.
Shall be Furosemide Injection, USP.
Shall be in accordance with the requirements of the USP.
All ingredients shall be of a pharmaceutical grade.
Shall contain 10 mg of Furosemide in each ml of injection within the applicable assay limits for the injection.
Workmanship. The injection shall be free from defects which detract from its appearance or impair its serviceability.
For Size 1 – Package (PG). Shall be supplied 2 ml in a commercial available container. One package containing 5 containers, as specified, constitutes one unit.
For Size 2 – Package (PG). Shall be supplied 10 ml in a commercial available container. One package containing 5 containers, as specified, constitutes one unit.
For Size 3 – Package (PG). Shall be supplied 4 ml in a commercial available syringe-needle unit. The needle shall be 22 gage 1-1/4 inches. One package containing 5 syringe-needle units, as specified, constitutes one unit.
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business